The therapeutic efficacy of long acting beta2 stimulant in patients with early stage COPD

Trial Profile

The therapeutic efficacy of long acting beta2 stimulant in patients with early stage COPD

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Jan 2015

At a glance

  • Drugs Tiotropium bromide (Primary) ; Indacaterol
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top